Tower Research Capital (TRC)’s OmniAb OABI Stock Holding History
Bought
Maintained
Sold
Other funds holding OABI
WCM
CCM
RHJA
PMG
Tower Research Capital (TRC)'s OABI Position: Q2 2026 in Review
Tower Research Capital (TRC) reduced its OmniAb (OABI) stake by 77% in Q2 2026, selling an estimated $54.1K and leaving 8,044 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3567.
Tower Research Capital (TRC) first reported a position in OABI in Q4 2021 and has held it in 17 quarters since. The position peaked at $146K in Q3 2023. 131 funds tracked by Wall St. Rank hold OABI as of Q2 2026.
- Tower Research Capital (TRC) held 8,044 shares of OmniAb worth $19.8K as of Q2 2026.
- Tower Research Capital (TRC) sold 27,262 OmniAb shares in Q2 2026, an estimated $54.1K.
- OmniAb made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3567 holding.
- Tower Research Capital (TRC) first reported a position in OmniAb in Q4 2021 and has held it in 17 quarters since.
- Tower Research Capital (TRC)'s OmniAb position peaked at $146K in Q3 2023.
- 131 funds tracked by Wall St. Rank held OmniAb as of Q2 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.